Literature DB >> 16232222

Altered phenotype and function of dendritic cells in children with type 1 diabetes.

F Angelini1, E Del Duca, S Piccinini, V Pacciani, P Rossi, M L Manca Bitti.   

Abstract

The importance of dendritic cells (DC) in the activation of T cells and in the maintenance of self-tolerance is well known. We investigated whether alterations in phenotype and function of DC may contribute to the pathogenesis of Type 1 diabetes (T1DM). Mature DC (mDC) from 18 children with T1DM and 10 age-matched healthy children were tested. mDC, derived from peripheral blood monocytes cultured for 6 days in presence of interleukin (IL)-4 and granulocyte-macrophage colony stimulating factor (GM-CSF) and stimulated with lipopolysaccharide (LPS) for the last 24 h, were phenotyped for the expression of the co-stimulatory molecules B7.1 and B7.2. In six patients and six controls allogenic mixed leucocyte reaction (AMLR) was performed using mDC and cord blood-derived naive T cells at a DC/T naive ratio of 1 : 200. Proliferation was assessed on day 7 by [(3)H]-thymidine incorporation assay. Mature DC derived from patients showed, compared with controls, a reduced expression of B7.1 [mean of fluorescence intensity (MFI): 36.2 +/- 14.3 versus 72.9 +/- 34.5; P = 0.004] and B7.2 (MFI: 122.7 +/- 67.5 versus 259.6 +/- 154.1; P = 0.02). We did not find differences in the HLA-DR expression (P = 0.07). Moreover, proliferative response of allogenic naive T cells cultured with mDC was impaired in the patients (13471 +/- 9917.2 versus 40976 +/- 24527.2 cpm, P = 0.04). We also measured IL-10 and IL-12 concentration in the supernatant of DC cultures. Interestingly, we observed in the patients a sevenfold higher level of IL-10 (P = 0.07) and a ninefold lower level of IL-12 (P = 0.01). Our data show a defect in the expression of the co-stimulatory molecules and an impairment of DC priming function, events that might contribute to T1DM pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16232222      PMCID: PMC1809519          DOI: 10.1111/j.1365-2249.2005.02916.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens.

Authors:  Jens Lohr; Birgit Knoechel; Shuwei Jiang; Arlene H Sharpe; Abul K Abbas
Journal:  Nat Immunol       Date:  2003-05-25       Impact factor: 25.606

Review 2.  Type I diabetes mellitus. A chronic autoimmune disease.

Authors:  G S Eisenbarth
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

Review 3.  Treatment of autoimmune disease by adoptive cellular gene therapy.

Authors:  Ingo H Tarner; Anthony J Slavin; Jacqueline McBride; Alenka Levicnik; Richard Smith; Garry P Nolan; Christopher H Contag; C Garrison Fathman
Journal:  Ann N Y Acad Sci       Date:  2003-09       Impact factor: 5.691

Review 4.  Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice.

Authors:  A H Sharpe
Journal:  Curr Opin Immunol       Date:  1995-06       Impact factor: 7.486

5.  Bone marrow abnormalities in the non-obese diabetic mouse.

Authors:  P B Langmuir; M M Bridgett; A L Bothwell; I N Crispe
Journal:  Int Immunol       Date:  1993-02       Impact factor: 4.823

6.  Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells.

Authors:  C Buelens; F Willems; A Delvaux; G Piérard; J P Delville; T Velu; M Goldman
Journal:  Eur J Immunol       Date:  1995-09       Impact factor: 5.532

7.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

Authors:  E A Tivol; F Borriello; A N Schweitzer; W P Lynch; J A Bluestone; A H Sharpe
Journal:  Immunity       Date:  1995-11       Impact factor: 31.745

8.  Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.

Authors:  K S Hathcock; G Laszlo; C Pucillo; P Linsley; R J Hodes
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

9.  Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse.

Authors:  Linda S Wicker; Giselle Chamberlain; Kara Hunter; Dan Rainbow; Sarah Howlett; Paul Tiffen; Jan Clark; Andrea Gonzalez-Munoz; Anne Marie Cumiskey; Raymond L Rosa; Joanna M Howson; Luc J Smink; Amanda Kingsnorth; Paul A Lyons; Simon Gregory; Jane Rogers; John A Todd; Laurence B Peterson
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

10.  Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.

Authors:  D J Lenschow; S C Ho; H Sattar; L Rhee; G Gray; N Nabavi; K C Herold; J A Bluestone
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  9 in total

1.  Altered Peripheral B-Lymphocyte Subsets in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults.

Authors:  Chao Deng; Yufei Xiang; Tingting Tan; Zhihui Ren; Chuqing Cao; Gan Huang; Li Wen; Zhiguang Zhou
Journal:  Diabetes Care       Date:  2015-12-30       Impact factor: 19.112

2.  The cross-regulatory relationship between human dendritic and regulatory T cells and its role in type 1 diabetes mellitus.

Authors:  Hsuen-Wen Chang; Yen-Hung Chow; Pele Chong; Charles Sia
Journal:  Rev Diabet Stud       Date:  2007-08-10

3.  Dendritic cells transduced to express interleukin 4 reduce diabetes onset in both normoglycemic and prediabetic nonobese diabetic mice.

Authors:  Melanie A Ruffner; Paul D Robbins
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

4.  Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.

Authors:  Thomas Enzler; Silke Gillessen; Michael Dougan; James P Allison; Donna Neuberg; Darryl A Oble; Martin Mihm; Glenn Dranoff
Journal:  Blood       Date:  2007-05-04       Impact factor: 22.113

5.  Critical immunological pathways are downregulated in APECED patient dendritic cells.

Authors:  Nora Pöntynen; Mari Strengell; Niko Sillanpää; Juha Saharinen; Ismo Ulmanen; Ilkka Julkunen; Leena Peltonen
Journal:  J Mol Med (Berl)       Date:  2008-07-04       Impact factor: 4.599

6.  Reduced number and function of peripheral dendritic cells in coeliac disease.

Authors:  R Ciccocioppo; G Ricci; B Rovati; I Pesce; S Mazzocchi; D Piancatelli; A Cagnoni; D Millimaggi; M Danova; G R Corazza
Journal:  Clin Exp Immunol       Date:  2007-06-20       Impact factor: 4.330

7.  Circulating fibrocyte mobilization in negative pressure wound therapy.

Authors:  Dezhi Chen; Yong Zhao; Zonghuan Li; Kangquan Shou; Xun Zheng; Pengcheng Li; Baiwen Qi; Aixi Yu
Journal:  J Cell Mol Med       Date:  2017-02-17       Impact factor: 5.310

8.  Role of plasmacytoid dendritic cells in type 1 diabetes: friend or foe?

Authors:  Roland Tisch; Bo Wang
Journal:  Diabetes       Date:  2009-01       Impact factor: 9.461

Review 9.  Advances in the cellular immunological pathogenesis of type 1 diabetes.

Authors:  Min Li; Lu-Jun Song; Xin-Yu Qin
Journal:  J Cell Mol Med       Date:  2014-03-14       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.